Diamicron MR 60mg
*Company:
Servier Laboratories Ireland LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 23 January 2023
File name
Diamicron MR 60mg SmPC.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 20 October 2022
File name
Diamicron 60mg PIL.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 02 April 2020
File name
Diamicron 60mg PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 4 - possible side effects
- Change to section 6 - what the product looks like and pack contents
Updated on 19 March 2020
File name
Diamicron MR 60mg SmPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 31 May 2016
File name
PIL_15520_692.pdf
Reasons for updating
- New PIL for new product
Updated on 31 May 2016
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 31 May 2016
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Correction of sulphonylurea by sulfonylurea in sections 4.2, 4.3, 4.8, 5.1.
Addition of St. John's Wort (Hypericum perforatum) preparations in sections 4.4 and 4.5 as products that may cause an increase in blood glucose levels.
Addition of dysglycaemia section in 4.4.
Addition of fluroniquinolones in section 4.5 as products that may cause dysglycaemia.
Updated on 31 May 2016
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Free text change information supplied by the pharmaceutical company
Correction of sulphonylurea by sulfonylurea in sections 4.2, 4.3, 4.8, 5.1.
Addition of St. John's Wort (Hypericum perforatum) preparations in sections 4.4 and 4.5 as products that may cause an increase in blood glucose levels.
Addition of dysglycaemia section in 4.4.
Addition of fluroniquinolones in section 4.5 as products that may cause dysglycaemia.
Updated on 17 June 2015
Reasons for updating
- Change to section 9 - Date of renewal of authorisation
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 17 June 2015
Reasons for updating
- Change to section 9 - Date of renewal of authorisation
Free text change information supplied by the pharmaceutical company
Updated on 09 October 2012
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 09 October 2012
Reasons for updating
- New SPC for medicines.ie